Rare diseases
Investigational molecules
Locations
Back to Belgium217 clinical trials in Brugge, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
BelgiumPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
BelgiumPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
BelgiumA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BelgiumStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
BelgiumPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
BelgiumStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
BelgiumEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
BelgiumSafety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease
BelgiumEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
BelgiumLetrozole During IVF/ICSI for Women with Endometriosis
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on viral infections and preventive measures, including trials evaluating new vaccines against influenza and cytomegalovirus. Research also covers treatment approaches for hepatitis B and invasive fungal infections.
Innovative approaches in vaccine development and antimicrobial therapies are being tested to combat various infectious diseases.
Comprehensive research into blood cancers and solid tumors, including studies on multiple myeloma, leukemia, and gastric cancer. Novel therapeutic approaches combine targeted treatments with immunotherapy.
Advanced treatment protocols are being evaluated to improve patient outcomes in various cancer types.
Studies addressing cardiovascular disease, obesity, and type 2 diabetes. Research focuses on innovative treatments and prevention strategies for major cardiovascular events.
Trials aim to improve cardiovascular outcomes and metabolic health through novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
